Welcome to RenValueSM
Sanofi is proud to help qualified patients with private insurance or no insurance cover the costs of Renvela® (sevelamer carbonate) tablets and for oral suspension through the RenValue program. RenValue is part of a portfolio of access programs sponsored by Sanofi.

Who can use the RenValue card?

Patients with private insurance
· Pay only $5 for each of 12 fills for claims up to $150.

Example: If you have a copay of $75 you pay $5; if you have a copay of $200 you pay $50.

Patients with no insurance
· Save up to $150 off out-of-pocket costs for each of 12 fills.
*Coupon not valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit program or other federal or state programs.

Example: If your out-of-pocket cost is $250, you pay $100 for each of 12 fills.


Coupon Thumbnail

To print the online RenValue coupon, click here.

To learn more about
Renvela, visit
www.renvela.com

To learn more about
Renassist®, visit
www.renassist.com

Who cannot use the RenValue card?
Patients participating in Medicaid, Medicare Part D, VA, IHS, or other federal or state programs are not eligible for this benefit.

If you or your patients do not qualify for RenValue, please call Renassist at 1-800-847-0069 and select option 2 to find out about what other services and assistance programs may be available.

Indication

Renvela® is used to control phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

Important Safety Information

  • Do not use Renvela if you have a history of bowel obstruction.
  • Talk to your doctor if you have had difficulty swallowing or swallowing disorders; or if you have had digestive tract surgery or other digestive disorders, including severe constipation.
  • The most frequently occurring side effects with Renvela tablets include nausea and vomiting.
  • Side effects with Renvela powder taken three times a day are similar to those reported for Renvela tablets.
  • The most common side effects with Renagel, which contains the same active ingredient as Renvela, include vomiting, nausea, diarrhea, indigestion, abdominal pain, flatulence, and constipation.
  • Cases of itching, rash, fecal impaction and, less commonly, slow bowel activity, bowel obstruction, and bowel perforation have been reported.
  • Uncommon cases of difficulty swallowing the Renvela tablet have been reported. Talk to your doctor if you have difficulty swallowing medicines in tablet form. Renvela for oral suspension may be considered by your doctor if you have a history of difficulty swallowing.
  • Your doctor should monitor your bicarbonate and chloride blood levels.
  • Reduced vitamins D, E, and K (clotting factors) and folic acid blood levels may be followed by your doctor.
  • Talk to your doctor when taking Renvela with other medications.
  • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on Renvela.
  • Take Renvela with meals and adhere to your prescribed diet.

Please see full Prescribing Information (PDF).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.